Skip to main content
    O

    Orthopediatrics Corp (KIDS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $31.50
    -0.85 (-2.63%)

    Market Cap: $844.67M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Orthopediatrics Corp (KIDS) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Orthopediatrics (KIDS) trades at 2.9x sales and 2.2x book value. Its P/S of 2.9x is below its 5-year median of 4.1x.

    Current Multiples

    Its free cash flow yield is 0.4%.

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales2.9x
    Price to book2.2x
    Price to FCF239.3x
    EV/FCF264.8x
    PEGN/A
    FCF yield0.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 57.4% below 6.8x and its P/B is 24.1% below 2.9x.

    MultipleCurrent5-year median10-year median
    P/S2.9x4.1x6.8x
    P/B2.2x1.8x2.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 104 to 109 months (10-year).

    Valuation History

    Over the 9 year ends shown, its P/S ranged from 1.2x in 2017 to 11.8x in 2021.

    Year endPriceP/SP/B
    2025$17.761.8x1.2x
    2024$23.182.6x1.5x
    2023$32.515.0x2.0x
    2022$39.736.7x2.4x
    2021$59.8611.8x5.1x
    2020$41.2510.5x3.4x
    2019$46.999.5x5.0x
    2018$34.887.6x5.6x
    2017$19.191.2x2.0x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About KIDS

    Is KIDS stock overvalued?

    GNG's valuation label for KIDS is Undervalued.

    What is KIDS's price to sales ratio?

    Orthopediatrics has a price to sales ratio of 2.9x.